-
1
-
2
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA
Published 2024-08-01Subjects: Get full text
Article -
3
Developability considerations for bispecific and multispecific antibodies
Published 2024-12-01Subjects: Get full text
Article -
4
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies
Published 2025-02-01Subjects: Get full text
Article -
5
Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
Published 2025-02-01Subjects: Get full text
Article -
6
Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
7
Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions
Published 2024-12-01Subjects: Get full text
Article -
8
-
9
Prodrug-based bispecific antibodies for cancer therapy: advances and future directions
Published 2025-01-01Subjects: “…bispecific antibodies…”
Get full text
Article -
10
-
11
A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins
Published 2025-01-01Subjects: Get full text
Article -
12
Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review
Published 2025-01-01Subjects: Get full text
Article -
13
Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies
Published 2024-12-01Subjects: Get full text
Article -
14
-
15
A cell-penetrating bispecific antibody suppresses hepatitis B virus replication and secretion
Published 2025-03-01Subjects: “…Cell-penetrating bispecific antibody…”
Get full text
Article -
16
Corrigendum: Editorial: Antiviral monoclonal antibody therapies
Published 2025-02-01Subjects: Get full text
Article -
17
Editorial: Antiviral monoclonal antibody therapies
Published 2024-10-01Subjects: Get full text
Article -
18
Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers
Published 2024-12-01Subjects: Get full text
Article -
19
Visual and High-Efficiency Secretion of SARS-CoV-2 Nanobodies with <i>Escherichia coli</i>
Published 2025-01-01Subjects: Get full text
Article -
20
A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies
Published 2024-12-01Subjects: “…Bispecific antibody…”
Get full text
Article